Drug intelligence / Profile preview

Qingyi No. 2 granule

Development stage
Unknown
Lead developer
Longhua Hospital Shanghai University of Traditional Chinese Medicine
Administration
Oral
01

Overview

Qingyi No. 2 granule is a traditional Chinese medicine (TCM) formulation developed by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is specifically indicated for the treatment of hemorrhagic fever with renal syndrome (HFRS), also known as epidemic hemorrhagic fever, during the febrile (fever) period. The granule is typically administered as an adjunct to standard Western medical treatments to prevent the progression of the disease into more severe or critical stages. As a botanical product, its therapeutic effect is derived from a combination of herbal ingredients intended to modulate the host immune response and manage systemic symptoms associated with hantavirus infection.

Other names
Qingyi II granuleQingyi No. 2
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Qingyi No. 2 granule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qingyi No. 2 granule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call